A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances
Author:
Affiliation:
1. School of Pharmaceutical Sciences, Key Laboratory of Chemical Biology, Ministry of Education, Shandong University, Jinan, China
2. Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China
Funder
Major Research Project of Shandong Province, P.R. China
Shandong Provincial Major Science &Technology Innovation Project, P.R. China
Major Basic Research Projects of Shandong Natural Science Foundation, P.R. China
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2021.1878366
Reference117 articles.
1. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
2. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations
3. Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
4. Nanotherapy for posterior eye diseases
5. Complications of intravitreal injections
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cubosomes; An Approach to Sustain and Improve the Ocular Delivery for Glaucoma Treatment: Box Benhken Optimization, Formulation, In Vitro Characterization and Ex Vivo Permeation Study;Journal for Research in Applied Sciences and Biotechnology;2024-07-21
2. Nanoparticle-based drug delivery systems: An updated strategy for treating fungal keratitis;Colloid and Interface Science Communications;2024-07
3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics;International Journal of Pharmaceutics;2024-06
4. Nanomicellar eye drops: a review of recent advances;Expert Opinion on Drug Delivery;2024-02-27
5. Multi-physics simulations for investigating the effect of electrode conditions on transscleral ocular iontophoresis for particulate drug delivery into ocular tissues;Biomedical Engineering Letters;2024-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3